Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Non-Dialysis (ASCEND-ND)

ClinicalTrials.gov ID: NCT02876835

Public ClinicalTrials.gov record NCT02876835. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 6:22 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3 Randomized, Open-label (Sponsor-blind), Active-controlled, Parallel-group, Multi-center, Event Driven Study in Non-dialysis Subjects With Anemia Associated With Chronic Kidney Disease to Evaluate the Safety and Efficacy of Daprodustat Compared to Darbepoetin Alfa

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this multi-center event-driven study in non-dialysis (ND) participants with anemia associated with chronic kidney disease (CKD) is to evaluate the safety and efficacy of daprodustat compared to darbepoetin alfa.

Study identification

NCT ID
NCT02876835
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
GlaxoSmithKline
Industry
Enrollment
3,872 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 99 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 27, 2016 (Actual)
Primary completion
Apr 19, 2021 (Actual)
Completion
Apr 19, 2021 (Actual)
Last update posted
Apr 2, 2024

2016 – 2021

United States locations

U.S. sites
161
U.S. states
34
U.S. cities
131
Facility City State ZIP Site status
GSK Investigational Site Andalusia Alabama 36420 —
GSK Investigational Site Birmingham Alabama 35249 —
GSK Investigational Site Huntsville Alabama 35805 —
GSK Investigational Site Glendale Arizona 85305 —
GSK Investigational Site Mesa Arizona 85202 —
GSK Investigational Site Phoenix Arizona 85016 —
GSK Investigational Site Phoenix Arizona 85027 —
GSK Investigational Site Scottsdale Arizona 48201 —
GSK Investigational Site Tucson Arizona 85745 —
GSK Investigational Site Azusa California 91702 —
GSK Investigational Site Bakersfield California 93308 —
GSK Investigational Site Bakersfield California 93309 —
GSK Investigational Site Chula Vista California 91910 —
GSK Investigational Site Cudahy California 90201 —
GSK Investigational Site El Centro California 92243 —
GSK Investigational Site Escondido California 92025 —
GSK Investigational Site Glendale California 91204 —
GSK Investigational Site Granada Hills California 91344 —
GSK Investigational Site La Mesa California 91942 —
GSK Investigational Site La Palma California 90623 —
GSK Investigational Site Long Beach California 90806 —
GSK Investigational Site Los Angeles California 90022 —
GSK Investigational Site Los Angeles California 90095 —
GSK Investigational Site Montebello California 90640 —
GSK Investigational Site National City California 91950 —
GSK Investigational Site Riverside California 92505 —
GSK Investigational Site San Diego California 92103 —
GSK Investigational Site San Diego California 92111 —
GSK Investigational Site San Luis Obispo California 93405 —
GSK Investigational Site Simi Valley California 93065 —
GSK Investigational Site Tarzana California 91356 —
GSK Investigational Site Whittier California 90602 —
GSK Investigational Site Middlebury Connecticut 06762 —
GSK Investigational Site Washington D.C. District of Columbia 20037 —
GSK Investigational Site Aventura Florida 33180 —
GSK Investigational Site Boca Raton Florida 33431 —
GSK Investigational Site Coral Gables Florida 33134 —
GSK Investigational Site Cutler Bay Florida 33189 —
GSK Investigational Site Doral Florida 33122 —
GSK Investigational Site Fort Lauderdale Florida 33308 —
GSK Investigational Site Homestead Florida 33033 —
GSK Investigational Site Hudson Florida 34667 —
GSK Investigational Site Jacksonville Florida 32224 —
GSK Investigational Site Jacksonville Florida 32256 —
GSK Investigational Site Lauderdale Lakes Florida 33313 —
GSK Investigational Site Miami Florida 33126 —
GSK Investigational Site Miami Florida 33143 —
GSK Investigational Site Miami Florida 33145 —
GSK Investigational Site Miami Florida 33147 —
GSK Investigational Site Miami Florida 33150 —
GSK Investigational Site Miami Florida 33155 —
GSK Investigational Site Miami Florida 33156 —
GSK Investigational Site Miami Florida 33165 —
GSK Investigational Site Miami Florida 33169 —
GSK Investigational Site Miami Florida 33173 —
GSK Investigational Site Miami Gardens Florida 33169 —
GSK Investigational Site Miami Lakes Florida 33014 —
GSK Investigational Site Ocala Florida 34471 —
GSK Investigational Site Orlando Florida 32810 —
GSK Investigational Site Pembroke Pines Florida 33028 —
GSK Investigational Site Port Charlotte Florida 33952 —
GSK Investigational Site South Miami Florida 33143 —
GSK Investigational Site Tampa Florida 33612 —
GSK Investigational Site Temple Terrace Florida 33637 —
GSK Investigational Site Atlanta Georgia 30342 —
GSK Investigational Site Augusta Georgia 30904 —
GSK Investigational Site Augusta Georgia 30909 —
GSK Investigational Site Augusta Georgia 30912 —
GSK Investigational Site Columbus Georgia 31904 —
GSK Investigational Site Nampa Idaho 83687 —
GSK Investigational Site Chicago Illinois 60611 —
GSK Investigational Site Chicago Illinois 60643 —
GSK Investigational Site Crystal Lake Illinois 60014 —
GSK Investigational Site Mount Prospect Illinois 60056 —
GSK Investigational Site Quincy Illinois 62301 —
GSK Investigational Site Springfield Illinois 62702 —
GSK Investigational Site Fort Wayne Indiana 46845 —
GSK Investigational Site Jeffersonville Indiana 47130 —
GSK Investigational Site Michigan City Indiana 46360 —
GSK Investigational Site Des Moines Iowa 50309 —
GSK Investigational Site Iowa City Iowa 52242 —
GSK Investigational Site Hutchinson Kansas 67502 —
GSK Investigational Site Wichita Kansas 67214 —
GSK Investigational Site Louisville Kentucky 40202 —
GSK Investigational Site Baton Rouge Louisiana 70808 —
GSK Investigational Site Baton Rouge Louisiana 70836 —
GSK Investigational Site Metairie Louisiana 70006 —
GSK Investigational Site Baltimore Maryland 21287 —
GSK Investigational Site Potomac Maryland 20854 —
GSK Investigational Site Takoma Park Maryland 20912-6385 —
GSK Investigational Site Boston Massachusetts 02114 —
GSK Investigational Site Detroit Michigan 48202 —
GSK Investigational Site Kalamazoo Michigan 49007 —
GSK Investigational Site Pontiac Michigan 48341 —
GSK Investigational Site Minneapolis Minnesota 55414 —
GSK Investigational Site Jackson Mississippi 39216 —
GSK Investigational Site Tupelo Mississippi 38801 —
GSK Investigational Site St Louis Missouri 63106 —
GSK Investigational Site St Louis Missouri 63110 —
GSK Investigational Site North Platte Nebraska 69101 —
GSK Investigational Site Las Vegas Nevada 89106 —
GSK Investigational Site Brooklyn New York 11203 —
GSK Investigational Site Buffalo New York 14215 —
GSK Investigational Site Flushing New York 11355 —
GSK Investigational Site Laurelton New York 11413 —
GSK Investigational Site New York New York 10021 —
GSK Investigational Site New York New York 10029 —
GSK Investigational Site Ridgewood New York 11385 —
GSK Investigational Site The Bronx New York 10461 —
GSK Investigational Site The Bronx New York 10467 —
GSK Investigational Site Yonkers New York 10704 —
GSK Investigational Site Charlotte North Carolina 28204 —
GSK Investigational Site Raleigh North Carolina 27609 —
GSK Investigational Site Rocky Mount North Carolina 27804 —
GSK Investigational Site Wilmington North Carolina 28401 —
GSK Investigational Site Winston-Salem North Carolina 27103 —
GSK Investigational Site Grand Forks North Dakota 58201 —
GSK Investigational Site Canton Ohio 15212 —
GSK Investigational Site Cincinnati Ohio 45206 —
GSK Investigational Site Cincinnati Ohio 45220 —
GSK Investigational Site Mentor Ohio 44060 —
GSK Investigational Site Lawton Oklahoma 73505 —
GSK Investigational Site Portland Oregon 97210 —
GSK Investigational Site Roseburg Oregon 97471 —
GSK Investigational Site Bethlehem Pennsylvania 18017 —
GSK Investigational Site Doylestown Pennsylvania 18901 —
GSK Investigational Site Lancaster Pennsylvania 17601 —
GSK Investigational Site Upland Pennsylvania 19013 —
GSK Investigational Site Wyomissing Pennsylvania 19610 —
GSK Investigational Site Anderson South Carolina 29621 —
GSK Investigational Site Charleston South Carolina 29425 —
GSK Investigational Site Columbia South Carolina 29209 —
GSK Investigational Site Sumter South Carolina 29150 —
GSK Investigational Site Cordova Tennessee 38018 —
GSK Investigational Site Knoxville Tennessee 37923 —
GSK Investigational Site Memphis Tennessee 38163 —
GSK Investigational Site Nashville Tennessee 37205 —
GSK Investigational Site Arlington Texas 76002 —
GSK Investigational Site Austin Texas 78751 —
GSK Investigational Site Austin Texas 78758 —
GSK Investigational Site Corpus Christi Texas 78404 —
GSK Investigational Site Corsicana Texas 75110 —
GSK Investigational Site Dallas Texas 75237 —
GSK Investigational Site Dallas Texas 75246 —
GSK Investigational Site Houston Texas 77004 —
GSK Investigational Site Houston Texas 77043 —
GSK Investigational Site Houston Texas 77084 —
GSK Investigational Site Houston Texas 77099 —
GSK Investigational Site Lufkin Texas 75904 —
GSK Investigational Site McAllen Texas 78503 —
GSK Investigational Site San Antonio Texas 78202 —
GSK Investigational Site San Antonio Texas 78212 —
GSK Investigational Site San Antonio Texas 78229 —
GSK Investigational Site San Antonio Texas 78258 —
GSK Investigational Site Temple Texas 76508 —
GSK Investigational Site Waxahachie Texas 75165 —
GSK Investigational Site Alexandria Virginia 22304 —
GSK Investigational Site Fairfax Virginia 22033 —
GSK Investigational Site Hampton Virginia 23666 —
GSK Investigational Site Salem Virginia 24153 —
GSK Investigational Site Bluefield West Virginia 24701 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 413 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02876835, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 2, 2024 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02876835 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →